NCT06312657View on ClinicalTrials.gov

Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

March 28, 2026

Study Completion Date

March 28, 2026

Conditions
Opioid Use Disorder
Interventions
BEHAVIORAL

Drug Cue

Individualized drug cues paired with choice options reinforced by $0.25

BEHAVIORAL

Money

Two money values will be tested ($0.25 and $4.00)

DRUG

Withdrawal

Participants will be maintained on an opioid agonist. Placebo will be substituted to produce mild-to-moderate withdrawal.

Trial Locations (1)

40506

RECRUITING

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Joshua A. Lile, Ph.D.

OTHER

NCT06312657 - Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice | Biotech Hunter | Biotech Hunter